Caplin Point gets nod for investment of up to $7 million in step down subsidiary

07 Aug 2018 Evaluate

Caplin Point Laboratories has received an approval for an investment in a step down subsidiary at El Salvador up to a limit of $7 million in Ordinary Shares and/ or Debt by its Wholly Owned Subsidiary  i.e. Caplin Point Far East. The Board of Directors of the company at their meeting held on August 06, 2018, approved the same.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1731.70 -9.55 (-0.55%)
22-Jan-2026 14:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1614.10
Dr. Reddys Lab 1217.50
Cipla 1371.95
Zydus Lifesciences 884.95
Lupin 2161.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×